BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 10213546)

  • 1. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 1996 Jun; 347(9017):1713-27. PubMed ID: 8656904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
    Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Last word on hormone replacement and breast cancer?].
    Rookus MA; van Leeuwen FE; Hamerlynck JV
    Ned Tijdschr Geneeskd; 1998 Jan; 142(3):111-3. PubMed ID: 9557006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Beral V; Reeves G; Bull D; Green J;
    J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer and hormone replacement therapy in the Million Women Study.
    Beral V; ; Bull D; Green J; Reeves G
    Lancet; 2007 May; 369(9574):1703-10. PubMed ID: 17512855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer and hormonal replacement therapy.
    Vassilopoulou-Sellin R
    Ann N Y Acad Sci; 2003 Nov; 997():341-50. PubMed ID: 14644841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopause, hormone replacement therapy and cancer.
    La Vecchia C; Brinton LA; McTiernan A
    Maturitas; 2001 Aug; 39(2):97-115. PubMed ID: 11514109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
    Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
    Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.